MDGL icon

Madrigal Pharmaceuticals
MDGL

Overview Fund Activity

256 hedge funds and large institutions have $6.41B invested in Madrigal Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 111 increasing their positions, 64 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
256
Holders Change
-11
Holders Change %
-4.12%
% of All Funds
3.72%
Holding in Top 10
14
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.2%
New
48
Increased
111
Reduced
64
Closed
54
Calls
$312M
Puts
$186M
Net Calls
+$126M
Net Calls Change
+$131M

Top Buyers

1
RI
1
RTW Investments
New York
$537M
2
BlackRock
2
BlackRock
New York
$400M
3
ACH
3
ArrowMark Colorado Holdings
Colorado
$52.5M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$506M
5
Bank of America
5
Bank of America
North Carolina
$67.1M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
BCLSI
2
Bain Capital Life Sciences Investors
Massachusetts
$0
3
PA
3
Perceptive Advisors
New York
$74.1M
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$696M
5
AG
5
Artal Group
Luxembourg
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
IGWM
301
ICA Group Wealth Management
Colorado
– -$24K -90 Closed
CA
302
CoreCap Advisors
Michigan
– -$18.2K -68 Closed
HT
303
Headlands Technologies
Illinois
– -$16.3K -61 Closed
AWM
304
Avior Wealth Management
Nebraska
– -$7.74K -29 Closed
BF
305
BOK Financial
Oklahoma
– -$2.56K -10 Closed
MAM
306
Meeder Asset Management
Ohio
– -$2.67K -10 Closed
FMTCOCP
307
Farmers & Merchants Trust Co of Chambersburg PA
Pennsylvania
– -$2K -8 Closed
WCM
308
Westend Capital Management
California
– -$1.07K -4 Closed
RAM
309
Riggs Asset Management
Pennsylvania
– -$535 -2 Closed
ACA
310
Atlas Capital Advisors
Wyoming
– -$267 -1 Closed
9 10 11 12
13